About
Amphastar P (NASDAQ:AMPH) — investor relations, events, news, and company updates on 6ix.
Latest News
Feb 26 2026
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2025
Feb 24 2026
Amphastar Announces FDA Approval for Ipratropium Bromide HFA
Feb 20 2026
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 26, 2026
Jan 12 2026
Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound
Jan 7 2026
Amphastar Pharmaceuticals to Present at the J.P. Morgan 2026 Healthcare Conference
Financials
Revenue
$719.89 M
Market Cap
$939.72 M
P/E Ratio
10.07
EPS
2.03
